Mark A. Kronenfeld, Director at Pacira Pharmaceuticals, Inc. (PCRX), bought 1,000 shares at $37.01 ($37K) on 2013-09-11, disclosed to the SEC on 2013-09-13.
Open-market purchase of $37k PCRX by Director. Below the thresholds we flag for high-conviction alerts (no C-suite role, rare reversal, cluster, or A-grade history).
Nothing distinguishes this filing.
| Filing → |
| PCRX | BUY | 2018-08-30 | $45K | — | Filing → |
| PCRX | BUY | 2017-11-13 | $42K | — | Filing → |
| PCRX | SELL | 2016-06-08 | $42K | — | Filing → |